Andrew Polovin Sells 1,130 Shares of Tempus AI, Inc. (NASDAQ:TEM) Stock

Tempus AI, Inc. (NASDAQ:TEM) EVP Andrew Polovin sold 1,130 shares of the business’s stock in a transaction dated Monday, December 16th. The shares were sold at an average price of $40.23, for a total value of $45,459.90. Following the completion of the transaction, the executive vice president now owns 244,955 shares in the company, valued at $9,854,539.65. This trade represents a 0.46 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Andrew Polovin also recently made the following trade(s):

• On Wednesday, December 11th, Andrew Polovin sold 51,504 shares of Tempus AI stock. The shares were sold at an average price of $42.39, for a total value of $2,183,254.56.

Tempus AI Price Performance

Tempus AI stock opened at $33.03 on Friday. The stock has a fifty day simple moving average of $51.96. Tempus AI, Inc. has a 52-week low of $22.89 and a 52-week high of $79.49. The company has a quick ratio of 2.55, a current ratio of 2.69 and a debt-to-equity ratio of 8.17.

Analyst Ratings Changes

Several equities research analysts recently weighed in on the company. Stifel Nicolaus downgraded Tempus AI from a “buy” rating to a “hold” rating and increased their price target for the stock from $45.00 to $65.00 in a report on Monday, November 11th. Guggenheim initiated coverage on shares of Tempus AI in a research note on Monday, December 9th. They issued a “buy” rating and a $74.00 target price for the company. Piper Sandler reiterated a “neutral” rating and set a $70.00 price target (up from $40.00) on shares of Tempus AI in a research note on Tuesday, November 12th. Bank of America increased their price target on shares of Tempus AI from $52.00 to $54.00 and gave the stock a “neutral” rating in a report on Friday, December 13th. Finally, Loop Capital lifted their price objective on Tempus AI from $48.00 to $57.00 and gave the company a “buy” rating in a report on Tuesday, October 15th. Three analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $56.00.

Institutional Trading of Tempus AI

Large investors have recently added to or reduced their stakes in the stock. NEA Management Company LLC purchased a new stake in shares of Tempus AI in the second quarter worth about $160,048,000. Novo Holdings A S purchased a new position in Tempus AI in the 2nd quarter worth approximately $142,605,000. Revolution Growth Management Company Inc. acquired a new stake in Tempus AI in the second quarter valued at approximately $128,133,000. ARK Investment Management LLC raised its stake in shares of Tempus AI by 355.0% during the third quarter. ARK Investment Management LLC now owns 2,378,157 shares of the company’s stock valued at $134,604,000 after purchasing an additional 1,855,459 shares during the period. Finally, Alphabet Inc. acquired a new position in shares of Tempus AI during the second quarter worth $54,289,000. 24.22% of the stock is currently owned by institutional investors and hedge funds.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.